DD
Therapeutic Areas
Cortigent Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Orion Visual Cortical Prosthesis System | Artificial vision for profound blindness (e.g., glaucoma, diabetic retinopathy, optic nerve injury) | Early Feasibility Study |
| Stroke Recovery System | Improvement of hand/arm movement recovery in partially paralyzed stroke patients | Preclinical |
Leadership Team at Cortigent
JA
Jonathan Adams
Chief Executive Officer & Director Nominee
ES
Edward Sedo
Chief Financial Officer
JC
Jerry Culp
Executive Consultant
TL
Truc Le
Consulting Chief Operating Officer
AM
Adam Mendelsohn
Chairman of the Board
JT
John T. Blake
Independent Director Nominee
JB
John Bowers
Independent Director Nominee
LS
Linda Szyper
Independent Director Nominee